Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Sep 9, 2017
Strategy

Some of the parts

Can Gilead apply its combination chops to make Kite CAR Ts work in solid tumors?
BioCentury | Aug 24, 2017
Translation in Brief

The skinny on leishmaniasis

Lethal Leishmania parasite abundant in skin patches
BioCentury | Mar 17, 2014
Company News

Gilead, Mylan sales and marketing update

BioCentury | Feb 10, 2014
Company News

Gilead, Mylan sales and marketing update

BioCentury | Jul 29, 2013
Company News

Taiwan Liposome sales and marketing update

BioCentury | Apr 15, 2013
Clinical News

Sequus preclinical data

BioCentury | Dec 19, 2011
Company News

Gilead, WHO infectious news

BioCentury | Aug 15, 2011
Company News

Gilead, Astellas infectious news

BioCentury | Oct 4, 2010
Clinical News

AmBisome amphotericin B regulatory update

Items per page:
1 - 10 of 148